Hudson Edge Investment Partners’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,334
Closed -$570K 91
2025
Q3
$570K Sell
10,334
-4,560
-31% -$237K 0.09% 82
2025
Q2
$642K Sell
14,894
-942
-6% -$36.3K 0.11% 78
2025
Q1
$627K Sell
15,836
-314
-2% -$13.9K 0.13% 78
2024
Q4
$658K Buy
16,150
+750
+5% +$31.2K 0.12% 90
2024
Q3
$601K Buy
15,400
+3,461
+29% +$138K 0.11% 86
2024
Q2
$522K Hold
11,939
0.1% 96
2024
Q1
$569K Hold
11,939
0.11% 89
2023
Q4
$564K Buy
11,939
+1,222
+11% +$50.8K 0.13% 82
2023
Q3
$510K Buy
10,717
+2,552
+31% +$139K 0.17% 83
2023
Q2
$475K Buy
+8,165
New +$490K 0.15% 89

Other funds holding NGVT

Hudson Edge Investment Partners's NGVT Position: Q4 2025 in Review

Hudson Edge Investment Partners sold out of Ingevity (NGVT) in Q4 2025, closing a stake of 10,334 shares — an estimated $570K sold.

Hudson Edge Investment Partners first reported a position in NGVT in Q2 2023 and held it in 10 quarters. The position peaked at $658K in Q4 2024. 303 funds tracked by Wall St. Rank hold NGVT as of Q4 2025.

  • Hudson Edge Investment Partners reported no remaining Ingevity position as of Q4 2025 after selling out during the quarter.
  • Hudson Edge Investment Partners sold 10,334 Ingevity shares in Q4 2025, an estimated $570K.
  • Hudson Edge Investment Partners first reported a position in Ingevity in Q2 2023 and held it in 10 quarters.
  • Hudson Edge Investment Partners's Ingevity position peaked at $658K in Q4 2024.
  • 303 funds tracked by Wall St. Rank held Ingevity as of Q4 2025.

Based on Hudson Edge Investment Partners's 13F filing for Q4 2025, filed 27 Jan 2026.